(688276)"Changchun Bcht Biotechnology Co."Report for Q3 2026
Filed with SSE · Stock code 688276 · · 15 pages · Chinese
Changchun BCHT Biotechnology Co. on 6ix
Earlier from Changchun BCHT Biotechnology
- (688276)"Changchun Bcht Biotechnology Co."Announcement on Convening the Q3 2026 Performance Briefing
- Announcement on Voluntary Disclosure Regarding the Acceptance of the Clinical Trial Application for the Combination Formulation of Recombinant Human Anti-Respiratory Syncytial Virus (RSV) Monoclonal Antibody Injection
- Semi-annual Report for 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Return of Previously Used Funds Raised for Temporary Working Capital Supplement and Use of a Portion of Idle Funds Raised for Temporary Working Capital Supplement
Follow Changchun BCHT Biotechnology into a list and get an email when it puts out news.
Follow Changchun BCHT Biotechnology